Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD microdosing dose-finding study
NL-OMON46425Active, not recruiting
- Sponsor
- Maastricht University
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Lysergide (4 arms), sponsored by Maastricht University. Primary endpoints: Subjective effects of LSD versus placebo and Change in cognitive performance under LSD versus placebo. Started May 2018; status: active, not recruiting.
02
Drugs
Lysergide
Beyond the preview
Go deeper on NL-OMON46425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46425.